341 related articles for article (PubMed ID: 15522382)
1. Impact of diabetes on glaucoma screening using frequency-doubling perimetry.
Realini T; Lai MQ; Barber L
Ophthalmology; 2004 Nov; 111(11):2133-6. PubMed ID: 15522382
[TBL] [Abstract][Full Text] [Related]
2. Performance of frequency-doubling technology perimetry in a population-based prevalence survey of glaucoma: the Tajimi study.
Iwase A; Tomidokoro A; Araie M; Shirato S; Shimizu H; Kitazawa Y;
Ophthalmology; 2007 Jan; 114(1):27-32. PubMed ID: 17070580
[TBL] [Abstract][Full Text] [Related]
3. The results of screening frequency doubling technology perimetry in different locations of the community.
Mansberger SL; Johnson CA; Cioffi GA
J Glaucoma; 2007 Jan; 16(1):73-80. PubMed ID: 17224754
[TBL] [Abstract][Full Text] [Related]
4. Testing for glaucoma with frequency-doubling perimetry in normals, ocular hypertensives, and glaucoma patients.
Horn FK; Wakili N; Jünemann AM; Korth M
Graefes Arch Clin Exp Ophthalmol; 2002 Aug; 240(8):658-65. PubMed ID: 12192460
[TBL] [Abstract][Full Text] [Related]
5. Frequency doubling technology perimetry abnormalities as predictors of glaucomatous visual field loss.
Medeiros FA; Sample PA; Weinreb RN
Am J Ophthalmol; 2004 May; 137(5):863-71. PubMed ID: 15126151
[TBL] [Abstract][Full Text] [Related]
6. Optimizing the use of frequency doubling technology perimetry in community vision screenings.
Nehmad L; Madonna RJ
Optom Vis Sci; 2008 Jul; 85(7):559-65. PubMed ID: 18594349
[TBL] [Abstract][Full Text] [Related]
7. Corneal thickness measurements and frequency doubling technology perimetry abnormalities in ocular hypertensive eyes.
Medeiros FA; Sample PA; Weinreb RN
Ophthalmology; 2003 Oct; 110(10):1903-8. PubMed ID: 14522761
[TBL] [Abstract][Full Text] [Related]
8. Frequency doubling perimetry and the detection of eye disease in the community.
Cioffi GA; Mansberger S; Spry P; Johnson C; Van Buskirk EM
Trans Am Ophthalmol Soc; 2000; 98():195-9; discussion 199-202. PubMed ID: 11190023
[TBL] [Abstract][Full Text] [Related]
9. Performance of efficient test procedures for frequency-doubling technology perimetry in normal and glaucomatous eyes.
Turpin A; McKendrick AM; Johnson CA; Vingrys AJ
Invest Ophthalmol Vis Sci; 2002 Mar; 43(3):709-15. PubMed ID: 11867588
[TBL] [Abstract][Full Text] [Related]
10. Sensitivity and specificity of frequency doubling perimetry in neuro-ophthalmic disorders: a comparison with conventional automated perimetry.
Wall M; Neahring RK; Woodward KR
Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1277-83. PubMed ID: 11923276
[TBL] [Abstract][Full Text] [Related]
11. Variability components of standard automated perimetry and frequency-doubling technology perimetry.
Spry PG; Johnson CA; McKendrick AM; Turpin A
Invest Ophthalmol Vis Sci; 2001 May; 42(6):1404-10. PubMed ID: 11328758
[TBL] [Abstract][Full Text] [Related]
12. Sensitivity and specificity of frequency-doubling technology, tendency-oriented perimetry, SITA Standard and SITA Fast perimetry in perimetrically inexperienced individuals.
Pierre-Filho Pde T; Schimiti RB; de Vasconcellos JP; Costa VP
Acta Ophthalmol Scand; 2006 Jun; 84(3):345-50. PubMed ID: 16704696
[TBL] [Abstract][Full Text] [Related]
13. Validation of test duration as a screening criterion for frequency doubling perimetry.
Thomas R; Parikh R; Muliyil J; Bhat S; George R
Am J Ophthalmol; 2004 Mar; 137(3):562-3. PubMed ID: 15013885
[TBL] [Abstract][Full Text] [Related]
14. Test-retest variability of frequency-doubling perimetry and conventional perimetry in glaucoma patients and normal subjects.
Chauhan BC; Johnson CA
Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):648-56. PubMed ID: 10067968
[TBL] [Abstract][Full Text] [Related]
15. Frequency doubling technology perimetry in open-angle glaucoma eyes with hemifield visual field damage: comparison of high-tension and normal-tension groups.
Murata H; Tomidokoro A; Matsuo H; Tomita G; Araie M
J Glaucoma; 2007 Jan; 16(1):9-13. PubMed ID: 17224743
[TBL] [Abstract][Full Text] [Related]
16. Frequency-doubling technology: searching for the optimum diagnostic criteria for glaucoma.
Ferreras A; Larrosa JM; Polo V; Pajarín AB; Mayoral F; Honrubia FM
Acta Ophthalmol Scand; 2007 Feb; 85(1):73-9. PubMed ID: 17244214
[TBL] [Abstract][Full Text] [Related]
17. Screening for glaucomatous visual field loss with frequency-doubling perimetry.
Johnson CA; Samuels SJ
Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):413-25. PubMed ID: 9040475
[TBL] [Abstract][Full Text] [Related]
18. Relationship between Humphrey 30-2 SITA Standard Test, Matrix 30-2 threshold test, and Heidelberg retina tomograph in ocular hypertensive and glaucoma patients.
Bozkurt B; Yilmaz PT; Irkec M
J Glaucoma; 2008; 17(3):203-10. PubMed ID: 18414106
[TBL] [Abstract][Full Text] [Related]
19. Learning effect among perimetric novices with screening C-20-1 frequency doubling technology perimetry.
Brush MB; Chen PP
Am J Ophthalmol; 2004 Mar; 137(3):551-2. PubMed ID: 15013879
[TBL] [Abstract][Full Text] [Related]
20. [The value of frequency doubling perimetry in glaucoma screening of aged 40 or more population].
Li JJ; Xu L; Zhang RX; Sun XY; Yang H; Zou Y; Zhao JL
Zhonghua Yan Ke Za Zhi; 2005 Mar; 41(3):221-5. PubMed ID: 15840362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
